Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Study of Selected X-linked Disorders: Goltz Syndrome
Pathogenesis of Focal Dermal Hypoplasia or Goltz Syndrome and Related Disorders
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Study of Selected X-linked Disorders: Goltz Syndrome
Pathogenesis of Focal Dermal Hypoplasia or Goltz Syndrome and Related Disorders
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Potential Research Study Participant Registry
Potential Research Study Participant Registry
Status: Enrolling
Updated:  12/31/1969
University of California-Davis
627
mi
from 98109
Sacramento, CA
Potential Research Study Participant Registry
Potential Research Study Participant Registry
Status: Enrolling
Updated: 12/31/1969
University of California-Davis
627
mi
from 98109
Sacramento, CA
Click here to add this to my saved trials
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents and Young Adults
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents and Young Adults
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Center for Excellence in Eye Care
2730
mi
from 98109
Miami, FL
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Center for Excellence in Eye Care
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
TLC Laser Eye Center
2312
mi
from 98109
Rockville, MD
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
TLC Laser Eye Center
2312
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
TLC Laser Eye Center
2311
mi
from 98109
Fairfax, VA
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
TLC Laser Eye Center
2311
mi
from 98109
Fairfax, VA
Click here to add this to my saved trials
Miltefosine to Treat Mucocutaneous Leishmaniasis
Treatment of Mucocutaneous Leishmaniasis With Miltefosine
Status: Enrolling
Updated:  12/31/1969
for this treatment IND, each Physician will enter patients at his/her own facility. Below data is for Protocol central contact
2312
mi
from 98109
Bethesda, MD
Miltefosine to Treat Mucocutaneous Leishmaniasis
Treatment of Mucocutaneous Leishmaniasis With Miltefosine
Status: Enrolling
Updated: 12/31/1969
for this treatment IND, each Physician will enter patients at his/her own facility. Below data is for Protocol central contact
2312
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Miltefosine to Treat Mucocutaneous Leishmaniasis
Treatment of Mucocutaneous Leishmaniasis With Miltefosine
Status: Enrolling
Updated:  12/31/1969
NIH
2315
mi
from 98109
Bethesda, MD
Miltefosine to Treat Mucocutaneous Leishmaniasis
Treatment of Mucocutaneous Leishmaniasis With Miltefosine
Status: Enrolling
Updated: 12/31/1969
NIH
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
Stanford University
704
mi
from 98109
Palo Alto, CA
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
Stanford University
704
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Health Sciences Ctr.
1026
mi
from 98109
Aurora, CO
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Health Sciences Ctr.
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
University of Iowa
1556
mi
from 98109
Iowa City, IA
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
University of Iowa
1556
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
2326
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
Boston University Medical Center
2485
mi
from 98109
Boston, MA
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
Boston University Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Medical Center
1393
mi
from 98109
Minneapolis, MN
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
Hospital for Special Surgery
2402
mi
from 98109
New York, NY
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
Columbia University
2400
mi
from 98109
New York, NY
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
Columbia University
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
Ohio State University
2006
mi
from 98109
Columbus, OH
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
Ohio State University
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
2134
mi
from 98109
Pittsburgh, PA
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern
1677
mi
from 98109
Dallas, TX
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern
1677
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
The University of Texas, Houston
1892
mi
from 98109
Houston, TX
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated:  12/31/1969
University of Utah
703
mi
from 98109
Salt Lake City, UT
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Enrolling
Updated: 12/31/1969
University of Utah
703
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis
An Open Label Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Treatment of Diffuse Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania Health System
2371
mi
from 98109
Philadelphia, PA
Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis
An Open Label Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Treatment of Diffuse Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania Health System
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Clear View Eye & Laser Medical Center
1052
mi
from 98109
San Diego, CA
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Clear View Eye & Laser Medical Center
1052
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Corneal Consultants of Colorado, P.C
1024
mi
from 98109
Littleton, CO
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Corneal Consultants of Colorado, P.C
1024
mi
from 98109
Littleton, CO
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Chicago Cornea Consultants, LTD
1704
mi
from 98109
Hoffman Estates, IL
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Chicago Cornea Consultants, LTD
1704
mi
from 98109
Hoffman Estates, IL
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Minnesota Eye Consultants
1392
mi
from 98109
Bloomington, MN
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Minnesota Eye Consultants
1392
mi
from 98109
Bloomington, MN
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Cornea Associates of Texas
1678
mi
from 98109
Dallas, TX
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Cornea Associates of Texas
1678
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia
Randomized Study of Safety and Effectiveness of Corneal Collagen Crosslinking and Intacs for Treatment of Keratoconus and Corneal Ectasia
Status: Enrolling
Updated:  12/31/1969
Cornea & Laser Eye Institute
2395
mi
from 98109
Teaneck, NJ
Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia
Randomized Study of Safety and Effectiveness of Corneal Collagen Crosslinking and Intacs for Treatment of Keratoconus and Corneal Ectasia
Status: Enrolling
Updated: 12/31/1969
Cornea & Laser Eye Institute
2395
mi
from 98109
Teaneck, NJ
Click here to add this to my saved trials
Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Medicine
2329
mi
from 98109
Baltimore, MD
Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Medicine
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia
Evaluation of Two Riboflavin Dosing Regimens for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus or Ectasia
Status: Enrolling
Updated:  12/31/1969
Price Vision Group
1862
mi
from 98109
Indianapolis, IN
Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia
Evaluation of Two Riboflavin Dosing Regimens for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus or Ectasia
Status: Enrolling
Updated: 12/31/1969
Price Vision Group
1862
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
Status: Enrolling
Updated:  12/31/1969
Cornea & Laser Eye Institute
2395
mi
from 98109
Teaneck, NJ
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
Status: Enrolling
Updated: 12/31/1969
Cornea & Laser Eye Institute
2395
mi
from 98109
Teaneck, NJ
Click here to add this to my saved trials
Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?
Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center
2294
mi
from 98109
Hershey, PA
Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?
Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
2294
mi
from 98109
Hershey, PA
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Schwartz Laser Eye Center
1117
mi
from 98109
Scottsdale, AZ
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Schwartz Laser Eye Center
1117
mi
from 98109
Scottsdale, AZ
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Harvard Eye Associates
998
mi
from 98109
Laguna Hills, CA
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Harvard Eye Associates
998
mi
from 98109
Laguna Hills, CA
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Clear View Eye & Laser Medical Center
1052
mi
from 98109
San Diego, CA
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Clear View Eye & Laser Medical Center
1052
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
681
mi
from 98109
San Francisco, CA
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
681
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Davidorf Eye Group
947
mi
from 98109
West Hills, CA
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Davidorf Eye Group
947
mi
from 98109
West Hills, CA
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Corneal Consultants of Colorado, P.C
1024
mi
from 98109
Littleton, CO
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Corneal Consultants of Colorado, P.C
1024
mi
from 98109
Littleton, CO
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Center for Excellence in Eye Care
2730
mi
from 98109
Miami, FL
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Center for Excellence in Eye Care
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Chicago Cornea Consultants, LTD
1704
mi
from 98109
Hoffman Estates, IL
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Chicago Cornea Consultants, LTD
1704
mi
from 98109
Hoffman Estates, IL
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
TLC Laser Eye Center
2312
mi
from 98109
Rockville, MD
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
TLC Laser Eye Center
2312
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Talamo Laser Eye Center
2476
mi
from 98109
Waltham, MA
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Talamo Laser Eye Center
2476
mi
from 98109
Waltham, MA
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
South Shore Eye Care LLP
2426
mi
from 98109
Wantagh, NY
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
South Shore Eye Care LLP
2426
mi
from 98109
Wantagh, NY
Click here to add this to my saved trials
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
TLC Laser Eye Center
2311
mi
from 98109
Fairfax, VA
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
TLC Laser Eye Center
2311
mi
from 98109
Fairfax, VA
Click here to add this to my saved trials